Baldassarre, M.P.A.; Di Dalmazi, G.; Coluzzi, S.; Carrieri, F.; Febo, F.; Centorame, G.; Cassino, P.; Piacentino, L.; Baroni, M.G.; Consoli, A.;
et al. Oral Semaglutide in Routine Clinical Practice: Characteristics of People with Type 2 Diabetes Started on the Drug and Changes in Their Clinical Parameters after 24 Weeks of Treatment. J. Clin. Med. 2024, 13, 3054.
https://doi.org/10.3390/jcm13113054
AMA Style
Baldassarre MPA, Di Dalmazi G, Coluzzi S, Carrieri F, Febo F, Centorame G, Cassino P, Piacentino L, Baroni MG, Consoli A,
et al. Oral Semaglutide in Routine Clinical Practice: Characteristics of People with Type 2 Diabetes Started on the Drug and Changes in Their Clinical Parameters after 24 Weeks of Treatment. Journal of Clinical Medicine. 2024; 13(11):3054.
https://doi.org/10.3390/jcm13113054
Chicago/Turabian Style
Baldassarre, Maria Pompea Antonia, Giulia Di Dalmazi, Sara Coluzzi, Federica Carrieri, Fabrizio Febo, Giorgia Centorame, Piergiuseppe Cassino, Luigi Piacentino, Marco Giorgio Baroni, Agostino Consoli,
and et al. 2024. "Oral Semaglutide in Routine Clinical Practice: Characteristics of People with Type 2 Diabetes Started on the Drug and Changes in Their Clinical Parameters after 24 Weeks of Treatment" Journal of Clinical Medicine 13, no. 11: 3054.
https://doi.org/10.3390/jcm13113054
APA Style
Baldassarre, M. P. A., Di Dalmazi, G., Coluzzi, S., Carrieri, F., Febo, F., Centorame, G., Cassino, P., Piacentino, L., Baroni, M. G., Consoli, A., & Formoso, G.
(2024). Oral Semaglutide in Routine Clinical Practice: Characteristics of People with Type 2 Diabetes Started on the Drug and Changes in Their Clinical Parameters after 24 Weeks of Treatment. Journal of Clinical Medicine, 13(11), 3054.
https://doi.org/10.3390/jcm13113054
